Categories: Health

Sutro Biopharma to Participate in Upcoming Investor

Published by
Globe News Wire


SOUTH SAN FRANCISCO, Calif., Nov. 23, 2022 (GLOBE NEWSWIRE) — Sutro Biopharma, Inc. (Sutro or the Company) (NASDAQ: STRO), a clinical-stage oncology company pioneering site-specific and novel-format antibody drug conjugates (ADCs), today announced that Bill Newell, Chief Executive Officer, will participate in two upcoming investor conferences. 

Presentation Details:

Piper Sandler 34th Annual Healthcare Conference
Format: Fireside Chat
Date: Wednesday, November 30, 2022
Time: 10:30 a.m. ET / 7:30 a.m. PT 
Location: New York

The JMP Securities Hematology and Oncology Summit
Format: Fireside Chat
Date: Tuesday, December 6, 2022
Time: 3:40 p.m. ET / 12:40 p.m. PT
Location: Virtual

The presentations will be accessible through the News & Events page of the Investor Relations section of the company’s website at www.sutrobio.com. Archived replays will be available for at least 30 days after the events.

About Sutro Biopharma

Sutro Biopharma, Inc., headquartered in South San Francisco, is a clinical-stage oncology company pioneering site-specific and novel-format antibody drug conjugates (ADCs). Sutro has two wholly owned ADCs in the clinic—STRO-002, a folate receptor alpha (FolRα)-targeting ADC, in clinical studies for ovarian and endometrial cancers; and STRO-001, a CD74-targeting ADC, in clinical studies for B-cell malignancies. Additionally, Sutro is collaborating with Bristol Myers Squibb (BMS) on CC-99712, a BCMA-targeting ADC in the clinic for patients with multiple myeloma; with Merck KGaA, Darmstadt, Germany, known as EMD Serono in the U.S. and Canada (EMD Serono), on M1231, a MUC1-EGFR bispecific ADC in clinical studies for patients with solid tumors, particularly non-small cell lung cancer (NSCLC) and esophageal squamous cell carcinoma; with Merck, known as MSD outside of the United States and Canada, on MK-1484, a selective IL-2 agonist in clinical studies as a monotherapy and in combination with pembrolizumab for the treatment of solid tumors; and with Astellas Pharma (Astellas) on novel modality, immunostimulatory antibody-drug conjugates (iADCs). Sutro’s platform technology also enabled the spin out of Vaxcyte and the creation of VAX-24, a 24-valent pneumococcal conjugate vaccine in clinical studies for the prevention of invasive pneumococcal disease. Sutro’s rational design and precise protein engineering has enabled six product candidates in the clinic. Follow Sutro on Twitter, @Sutrobio, and at www.sutrobio.com to learn more about our passion for changing the future of oncology.

Investor Contact
Annie J. Chang
Sutro Biopharma
(650) 801-5728
ajchang@sutrobio.com 

Media Contact
Amy Bonanno
Solebury Strategic Communications
(914) 450-0349
abonanno@soleburystrat.com

Globe News Wire
Share
Published by
Globe News Wire

Recent Posts

2022 World Textile Merchandising Conference Opens to Explore New Trends in Industry

SHAOXING, China--(BUSINESS WIRE)--The fifth edition of the World Textile Merchandising Conference (WTMC) opened on Nov.… Read More

1 hour ago

Philips advances AI-powered diagnostic systems and

November 27, 2022 Latest innovations feature vendor-neutral solutions to help reduce clinical complexity and enhance… Read More

2 hours ago

Cyber Monday Hoverboard Deals 2022: Top Jetson, Segway, GOTRAX, Razor & More Savings Tracked by Retail Fuse

The best hoverboard deals for Cyber Monday 2022, featuring savings on hoverboards & hoverboard go… Read More

2 hours ago

Konica Minolta Healthcare Transforms the Future of X-ray in

WAYNE, N.J., Nov. 27, 2022 (GLOBE NEWSWIRE) -- Konica Minolta Healthcare Americas, Inc. announced today… Read More

3 hours ago

Rowing Machine Cyber Monday Deals 2022: Top ProForm, NordicTrack, Hydrow, Ergatta & More Water Rower Sales Ranked by Consumer Articles

Cyber Monday rowing machine deals have arrived, compare all the best Black Friday & Cyber… Read More

3 hours ago

VPN Cyber Monday Deals 2022: NordVPN, IPVanish, Surfshark, ExpressVPN & More Deals Published by Saver Trends

The best Cyber Monday VPN deals for 2022, featuring all the best annual & monthly… Read More

4 hours ago